Загрузка страницы

Dr. Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation - Improving People’s Lives Globally

Dr. Mads Krogsgaard Thomsen, DVM, DSc., Ph.D., is the CEO of the Novo Nordisk Foundation (https://novonordiskfonden.dk/), an international foundation with a dual objective: to provide a stable basis for the commercial and research activities conducted by the companies within the Novo Group (of which Novo Nordisk A/S is the largest holdings) and to support scientific, humanitarian and social purposes. In 2020, the Novo Nordisk Foundation had a net worth of US$73.1 billion, making it the largest financial endowment in the world. Novo Nordisk Foundation owns Novo Holdings A/S, a holding company and majority shareholder of Novo Nordisk, as well as Novozymes, a global biotechnology company focused on the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The foundation is also a major shareholder in more than 75 other companies.

Originally, trained as a veterinarian / DVM at The Royal Veterinary and Agricultural University (now part of the University of Copenhagen), where he also holds a DSc. in this domain, Dr. Thomsen started his career as a PhD pharmacology student at the University of Copenhagen, after which he worked three years as a researcher at LEO Pharma. Thirty years ago, he joined Novo Nordisk, initially as Head of Growth Hormone Research and subsequently as Senior Vice President of Diabetes R&D. In 1995, he was appointed Senior Vice President of Discovery and in 2000, he became Executive Vice President of Research & Development/Chief Scientific Officer. Over the years, he has headed the development of 20 medical drugs, especially within diabetes treatment and the groundbreaking development of GLP-1 technologies.

Dr. Thomsen has served as President of the Danish Academy of Technical Sciences and Chairman of the Board of the University of Copenhagen, where he is also an adjunct professor of Pharmacology.

Видео Dr. Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation - Improving People’s Lives Globally канала Progress, Potential, and Possibilities
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
10 января 2022 г. 21:37:29
00:31:34
Другие видео канала
Dr. Stephen Johnston, PhD - Calviri - Cancer Eradication Via A Universal Preventative Cancer VaccineDr. Stephen Johnston, PhD - Calviri - Cancer Eradication Via A Universal Preventative Cancer VaccineFanny Sie - One Roche Head of Artificial Intelligence and Digital Health - F. Hoffmann-La Roche Ltd.Fanny Sie - One Roche Head of Artificial Intelligence and Digital Health - F. Hoffmann-La Roche Ltd.Dr. Jessica Whited, Ph.D. - Harvard University - Exploring The Biology Of Limb RegenerationDr. Jessica Whited, Ph.D. - Harvard University - Exploring The Biology Of Limb RegenerationDr. Jarah Meador, Ph.D. - Director, Open Innovation Programs - U.S. General Services AdministrationDr. Jarah Meador, Ph.D. - Director, Open Innovation Programs - U.S. General Services AdministrationDr. Eric Bapteste, Ph.D. - CNRS/AIRE - Interactomics For Deeper Understanding Of Aging And EvolutionDr. Eric Bapteste, Ph.D. - CNRS/AIRE - Interactomics For Deeper Understanding Of Aging And Evolution#Secretary Dr #DonnaShalala Discussing #Aging #Pandemic #Preparedness and #PublicHealth#Secretary Dr #DonnaShalala Discussing #Aging #Pandemic #Preparedness and #PublicHealthDr Joel Mozer, PhD - United States Space Force - Director of Science, Technology, and ResearchDr Joel Mozer, PhD - United States Space Force - Director of Science, Technology, and ResearchDr. Sharon K. Inouye, MD, MPH - Director, Aging Brain Center, HSL; Professor, Harvard Medical SchoolDr. Sharon K. Inouye, MD, MPH - Director, Aging Brain Center, HSL; Professor, Harvard Medical SchoolDr. Andrew Hebbeler, Ph.D. - Office of Science and Technology Policy (OSTP) - The White HouseDr. Andrew Hebbeler, Ph.D. - Office of Science and Technology Policy (OSTP) - The White HouseDr Mark Shrime, MD - International Chief Medical Officer, Mercy Ships - Prof, Harvard Medical SchoolDr Mark Shrime, MD - International Chief Medical Officer, Mercy Ships - Prof, Harvard Medical SchoolDr. Emily Osborne Ph.D. - Research Scientist - Ocean Chemistry and Ecosystems Division - NOAA/AOMLDr. Emily Osborne Ph.D. - Research Scientist - Ocean Chemistry and Ecosystems Division - NOAA/AOMLDr. Amy Throckmorton, PhD - BioCirc / Drexel University - Innovating Life-Saving Therapeutic DevicesDr. Amy Throckmorton, PhD - BioCirc / Drexel University - Innovating Life-Saving Therapeutic DevicesDr. Aysha Akhtar, MD, MPH - Using Science To Do Good For Humans, Animals And The PlanetDr. Aysha Akhtar, MD, MPH - Using Science To Do Good For Humans, Animals And The PlanetAlistair Fulton - Connecting & Enabling A Smarter Planet - VP, Wireless & Sensing Products, SemtechAlistair Fulton - Connecting & Enabling A Smarter Planet - VP, Wireless & Sensing Products, SemtechMichael Lahiff - CEO, ZeroEyes - A.I. Gun Detection Technology To Aid First Responders & Save LivesMichael Lahiff - CEO, ZeroEyes - A.I. Gun Detection Technology To Aid First Responders & Save LivesDr. Michael Ott, Ph.D. - SVP and Chief Research and Development Officer - The Clorox CompanyDr. Michael Ott, Ph.D. - SVP and Chief Research and Development Officer - The Clorox CompanyDr Renée Deehan - VP, Science & AI, InsideTracker - Evidence-Based & Actionable Healthspan SolutionsDr Renée Deehan - VP, Science & AI, InsideTracker - Evidence-Based & Actionable Healthspan SolutionsDr. Jana Dickter, MD - City of Hope - Managing Complex Infections In Difficult to Treat CasesDr. Jana Dickter, MD - City of Hope - Managing Complex Infections In Difficult to Treat CasesDr. Sadid Hasan, PhD - AI Lead, Microsoft - Developing Transformational AI Leaders For Global ImpactDr. Sadid Hasan, PhD - AI Lead, Microsoft - Developing Transformational AI Leaders For Global ImpactDr Haileyesus Getahun, MD, MPH, PhD - WHO - Leading The Fight Against Antimicrobial Resistance (AMR)Dr Haileyesus Getahun, MD, MPH, PhD - WHO - Leading The Fight Against Antimicrobial Resistance (AMR)
Яндекс.Метрика